Niagen Bioscience Inc (NAGE)
NASDAQ: NAGE
· Real-Time Price · USD
9.48
-0.15 (-1.56%)
At close: Aug 20, 2025, 10:02 AM
-1.56% (1D)
| Bid | 9.45 |
| Market Cap | 756.06M |
| Revenue (ttm) | 107.92M |
| Net Income (ttm) | 14.11M |
| EPS (ttm) | 0.22 |
| PE Ratio (ttm) | 43.09 |
| Forward PE | 39 |
| Analyst | Strong Buy |
| Ask | 9.51 |
| Volume | 73,202 |
| Avg. Volume (20D) | 1,116,519 |
| Open | 9.52 |
| Previous Close | 9.63 |
| Day's Range | 9.37 - 9.61 |
| 52-Week Range | 3.10 - 14.69 |
| Beta | 2.13 |
About NAGE
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol NAGE
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for NAGE stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Niagen Bioscience Inc is scheduled to release its earnings on
Oct 30, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
1 week ago
+2.23%
Niagen Bio shares are trading higher after reporti...
Unlock content with
Pro Subscription
1 week ago
+2.62%
Niagen Bio shares are trading higher after reporting better-than-expected Q2 financial results.
2 months ago · businesswire.com
Niagen Bioscience to Participate at the Roth 15th Annual London ConferenceLOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the...
2 months ago · businesswire.com
Niagen Bioscience to Participate in the BIO 2025 International ConventionLOS ANGELES--(BUSINESS WIRE)---- $NAGE #Biotech--Niagen Bioscience, Inc. (NASDAQ: NAGE) (formerly ChromaDex Corp.), the global authority on NAD+ (nicotinamide adenine dinucleotide) with a focus on the...
